Atomistry » Fluorine » PDB 8hy7-8ijv » 8i7l
Atomistry »
  Fluorine »
    PDB 8hy7-8ijv »
      8i7l »

Fluorine in PDB 8i7l: Crystal Structure of Indoleamine 2,3-Dioxygenagse 1 (IDO1) Complexed with A Novel Inhibitor

Enzymatic activity of Crystal Structure of Indoleamine 2,3-Dioxygenagse 1 (IDO1) Complexed with A Novel Inhibitor

All present enzymatic activity of Crystal Structure of Indoleamine 2,3-Dioxygenagse 1 (IDO1) Complexed with A Novel Inhibitor:
1.13.11.52;

Protein crystallography data

The structure of Crystal Structure of Indoleamine 2,3-Dioxygenagse 1 (IDO1) Complexed with A Novel Inhibitor, PDB code: 8i7l was solved by K.Li, W.Liu, X.Dong, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 48.56 / 2.80
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 87.11, 97.11, 128.45, 90, 90, 90
R / Rfree (%) 27 / 29.3

Other elements in 8i7l:

The structure of Crystal Structure of Indoleamine 2,3-Dioxygenagse 1 (IDO1) Complexed with A Novel Inhibitor also contains other interesting chemical elements:

Chlorine (Cl) 2 atoms

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Crystal Structure of Indoleamine 2,3-Dioxygenagse 1 (IDO1) Complexed with A Novel Inhibitor (pdb code 8i7l). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Crystal Structure of Indoleamine 2,3-Dioxygenagse 1 (IDO1) Complexed with A Novel Inhibitor, PDB code: 8i7l:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 8i7l

Go back to Fluorine Binding Sites List in 8i7l
Fluorine binding site 1 out of 2 in the Crystal Structure of Indoleamine 2,3-Dioxygenagse 1 (IDO1) Complexed with A Novel Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Crystal Structure of Indoleamine 2,3-Dioxygenagse 1 (IDO1) Complexed with A Novel Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F502

b:86.1
occ:1.00
F1 A:OIH502 0.0 86.1 1.0
C24 A:OIH502 1.4 87.2 1.0
C23 A:OIH502 2.4 87.6 1.0
C25 A:OIH502 2.4 88.9 1.0
N4 A:OIH502 2.8 85.0 1.0
CG2 A:VAL130 3.1 84.9 1.0
CE2 A:PHE163 3.1 75.6 1.0
CD1 A:PHE164 3.5 85.4 1.0
CD2 A:PHE163 3.5 78.2 1.0
C28 A:OIH502 3.6 90.5 1.0
C26 A:OIH502 3.7 89.0 1.0
OG A:SER167 3.8 56.9 1.0
C22 A:OIH502 3.8 82.8 1.0
CE1 A:PHE164 3.9 85.3 1.0
CZ A:PHE163 4.0 75.2 1.0
CB A:SER167 4.1 65.2 1.0
C27 A:OIH502 4.1 89.8 1.0
O A:PHE163 4.2 83.8 1.0
O3 A:OIH502 4.2 82.3 1.0
CE1 A:TYR126 4.3 89.2 1.0
CD1 A:TYR126 4.4 89.7 1.0
CA A:PHE164 4.5 84.1 1.0
CB A:VAL130 4.6 85.0 1.0
CG A:PHE163 4.6 80.0 1.0
CG A:PHE164 4.7 85.7 1.0
C A:PHE163 4.7 84.2 1.0
N3 A:OIH502 4.8 82.4 1.0
N A:PHE164 4.9 85.0 1.0
CL1 A:OIH502 5.0 89.0 1.0
CE1 A:PHE163 5.0 76.0 1.0

Fluorine binding site 2 out of 2 in 8i7l

Go back to Fluorine Binding Sites List in 8i7l
Fluorine binding site 2 out of 2 in the Crystal Structure of Indoleamine 2,3-Dioxygenagse 1 (IDO1) Complexed with A Novel Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Crystal Structure of Indoleamine 2,3-Dioxygenagse 1 (IDO1) Complexed with A Novel Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F501

b:99.3
occ:1.00
F1 B:OIH501 0.0 99.3 1.0
C24 B:OIH501 1.4 97.9 1.0
C23 B:OIH501 2.4 95.7 1.0
C25 B:OIH501 2.4 97.4 1.0
N4 B:OIH501 2.8 96.5 1.0
CE2 B:PHE163 3.0 72.8 1.0
CG2 B:VAL130 3.1 59.8 1.0
CD2 B:PHE163 3.4 74.6 1.0
OG B:SER167 3.5 70.4 1.0
CD1 B:PHE164 3.6 88.9 1.0
C28 B:OIH501 3.7 95.9 1.0
C26 B:OIH501 3.7 97.4 1.0
CZ B:PHE163 3.8 72.6 1.0
CB B:SER167 3.9 70.4 1.0
C22 B:OIH501 3.9 96.5 1.0
CE1 B:PHE164 3.9 89.3 1.0
O B:PHE163 4.0 80.3 1.0
C27 B:OIH501 4.2 96.5 1.0
O3 B:OIH501 4.3 96.5 1.0
CE1 B:TYR126 4.4 72.6 1.0
CA B:PHE164 4.4 79.9 1.0
CD1 B:TYR126 4.4 73.0 1.0
CG B:PHE163 4.5 77.6 1.0
C B:PHE163 4.6 81.6 1.0
CB B:VAL130 4.6 72.5 1.0
CG B:PHE164 4.7 87.8 1.0
N B:PHE164 4.8 81.8 1.0
CE1 B:PHE163 4.8 74.5 1.0
N3 B:OIH501 4.9 97.3 1.0
CL1 B:OIH501 5.0 98.5 1.0

Reference:

K.Li, W.Liu, X.Dong. Apo-Form Selective Inhibition of Ido For Tumor Immunotherapy Journal of Immunology V. 209 180 2022.
ISSN: ISSN 00221767
DOI: 10.4049/JIMMUNOL.2100938
Page generated: Wed Jul 16 05:34:10 2025

Last articles

Fe in 2YXO
Fe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy